Vita Imaging
A Revolutionary Breakthrough in Skin Cancer Detection
Overview
Raised: $352,670
Total Commitments ($USD)
Dealmaker Securities
02/27/2024
08/26/2024
$570
Equity - Common
Series B
RegCF
$5.70
$40,100,000
Rolling Commitments ($USD)
Active
05/01/2024
116
2,351%
9%
$5,510
44
2018
Healthcare & Pharmaceuticals
HealthTech
B2B
Medium
High
Summary Profit and Loss Statement
| FY 2023 | FY 2022 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-1,624,936 |
$-837,822 |
Summary Balance Sheet
| FY 2023 | FY 2022 | |
|---|---|---|
|
Cash |
$121,086 |
$46,568 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$534,788 |
$330,089 |
|
Short-Term Debt |
$1,709,273 |
$294,502 |
|
Long-Term Debt |
$0 |
$662,297 |
|
Total Liabilities |
$1,709,273 |
$956,799 |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Updates
In this company update, we look at Vita Imaging announcing a new crowdfunding round on Dealmaker at a $40.1M valuation, reflecting its progress in FDA approval and current financial situation.